Key result
Noninducible AF post-ablation links to ~474% higher recurrence risk, while nonPV triggers blunt LVEF improvement.
Why the study?
AF inducibility and nonPV triggers in HF patients, as well as the link between triggers and post-ablation LV function changes, remain unclear.
Does AF inducibility and trigger type predict AF recurrence and LVEF improvement in patients with tachycardia-induced heart failure undergoing catheter ablation?
Cohort (n=101)
Does AF inducibility and trigger type predict AF recurrence and LVEF improvement in patients with tachycardia-induced heart failure undergoing catheter ablation?
Effect estimate: HR 5.74 (95% CI 1.81-18.13)
In patients with tachycardia-induced heart failure undergoing AF ablation, noninducible AF predicts higher recurrence, while non-pulmonary vein triggers predict less LVEF improvement.
Inducibility status and trigger type may help predict outcomes after ablation for tachycardia-induced HF; this observational study leaves open the need for confirmatory trials.
BACKGROUND: The inducibility of atrial fibrillation (AF) and incidence of nonpulmonary vein (nonPV) triggers in patients with heart failure (HF) have not been elucidated. Furthermore, the relationship between AF triggers and the change in the left ventricular (LV) function after catheter ablation (CA) remains unclear. METHODS: A total of 101 consecutive patients with a history of HF due to tachycardia who underwent CA of AF were prospectively enrolled (64.8 ± 10.7 years, male 72.3%, and paroxysmal AF 15.8%). According to the AF inducibility by isoproterenol (ISP), the patients were divided into two groups: inducible AF (66.3%) and noninducible AF (33.7%). Furthermore, inducible AF was categorized into a PV type (61.2%) and nonPV type (38.8%). This study investigated the AF recurrence and change in the LV ejection fraction (LVEF) after CA. RESULTS: AF recurred in 35 patients (34.7%) during the follow-up period (41.6 ± 26.8 months). Kaplan-Meier curves showed that patients with noninducible AF had just as bad an AF recurrence rate as those with the nonPV type. Cox proportional hazards models also revealed that noninducible AF (Hazard-ratio, 5.74; 95% CI, 1.81-18.13) was associated with a higher risk of recurrence. The LVEF significantly improved after the CA (from 49.1 ± 16.3% to 67.0 ± 7.9%). However, the nonPV type was associated with a lower improvement in the LVEF (Odds-ratio, 0.18; 95% CI, 0.05-0.70). CONCLUSION: The AF inducibility was associated with AF recurrence. Furthermore, the nonPV triggers were associated with a lesser improvement in the LVEF. Confirming the AF inducibility and triggers was important to predict the outcome after CA.
No takes yet. Share an insight, caveat, or question.
Koike et al. (2022) conducted a cohort in Atrial fibrillation with tachycardia-induced heart failure (n=101). Catheter ablation vs. Inducible vs noninducible AF by isoproterenol was evaluated on Atrial fibrillation recurrence (HR 5.74, 95% CI 1.81-18.13). Noninducible atrial fibrillation after catheter ablation was associated with a higher risk of recurrence (HR 5.74; 95% CI 1.81-18.13), while nonPV triggers predicted lesser LVEF improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: